The Lymphoma Program at Weill Cornell Medical College invites you to hear from our experts about the latest advances in lymphoma treatment & nutrition:
Tag: Weill Cornell Medical College
REDLAMP 2: Disease Characteristics, Treatment Patterns, Prognosis, Outcomes, and Lymphoma-Related Mortality in Elderly Follicular Lymphoma
In a recent publication from the British Journal of Haematology researchers sought to better understand how patients over the age of 80 should be treated when they are diagnosed with follicular lymphoma. Dr. John Leonard discusses the implications of several of this study’s findings. Researchers found that while elderly follicular lymphoma patients were treated less aggressively, the majority of patients lived through the course of the study, with only a minority of those who died, dying from follicular lymphoma.
You can follow Lymphoma Program Director John Leonard @JohnPLeonardMD.
The previous entry can be viewed here.
We encourage you to follow the Lymphoma Program on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 646-962-2074.
REDLAMP – Review of Emerging Data for Lymphoma Patients – “Video Journal Club” Launched by Weill Cornell Lymphoma Program
The Lymphoma Program at Weill Cornell Medical College, Meyer Cancer Center, and NewYork-Presbyterian is pleased to announce the initiation of a novel program to better inform patients and families dealing with lymphoma, chronic lymphocytic leukemia, and related disorders.
We will be presenting regular (roughly weekly) video programs where faculty briefly (3-5 minutes) review a new research publication that is important for lymphoma patients to learn about in terms that are understandable and relevant. The topics will be selected by our expert lymphoma faculty based on their importance to the field and our desire to make sure that lymphoma patients learn about new developments in a timely fashion.
The program will be named “REDLAMP” – Review of Emerging Data for Lymphoma Patients. Beyond the acronym, RED is also a nod to the colors of Weill Cornell Medical College, Cornell University and NewYork-Presbyterian (and blood cancers in general), while “LAMP” references our desire to “shine light” on important information for patients.
Our first video can be found below:
You can follow Lymphoma Program Director John Leonard @JohnPLeonardMD.
We encourage you to follow us on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 646-962-2074.
New Developments in Lymphoma 